PubMed Health⌕ Search

Biomedical subjects

Z Bouayad

Publications and source records attributed to Z Bouayad.

25 records · Page 2Linked to original sources
PubMed1995

[Treatment of pleural tuberculosis with a short 4-month regimen: preliminary results].

The aim of this prospective study was to evaluate the results of a four-month regimen (2HRZ/2HR) in the treatment of isolated tuberculous pleurisy with effusion. It included 68 patients presenting with histologically confirmed tuberculous pleurisy treated with 2HRZ/2HR, physiotherapy and aspiration of the pleura. Patients were seen every 2 months during treatment, and then 1, 3, 4, 6, 12, and 24 months after the end of treatment. Preliminary results show a favourable response in 58 patients (85%) and minimal pleural thickening in 10 patients. There were no failures, no relapses nor any extrapleural dissemination after a follow-up period of on average 20 months. These encouraging results need to be evaluated in a long-term study.

Adult↗
PubMed1994

[Pleural fibrous mesothelioma. Apropos of a case].

A 27-year-old man with an uneventful history was hospitalized after fortuitous discovery of an opacity in the right lung field. The clinical examination revealed a multi-nodular euthyroidian goiter. Laboratory tests, including blood glucose, were normal. Computed tomography of the chest showed a pleural formation and associated pleural effusion. Complete surgical exeresis led to the diagnosis of benign fibrous pleural mesothelioma. Fibromas of the pleura are rare and usually discovered due to extra thoracic signs. The clinical course is long and often silent. Surgical removal is indicated and usually is complete.

Adult↗
PubMed1992

[Clinical characteristics and etiology in hemoptysis in a pneumology service. 291 cases].

The aim of this work is to determine the clinical characteristics of haemoptysis and their principal aetiologies in a retrospective study of 291 cases collected over 5 years and occurring in adults who were hospitalised in a pneumology service. The annual incidence of haemoptysis was 8.8% of the in-patient population. The mean age of the patients was 46 and 47% were less than 50. The males were most frequent (69.4%) and haemoptysis was the presenting feature in 35.4%; it was minimal in 71.1% of average quantity in 26.8% and severe in 2.1%. The thoracic radiograph was judged abnormal in all cases and the abnormalities noted were suggestive of a particular aetiology in 70.8% of cases. The aetiological cause was dominated by bronchial cancer and of active pulmonary tuberculosis or its sequalae with levels of 34.4% and 18.9% respectively. For the other causes bronchial dilatation was important with 15.1% and hydatic cysts another 9.3%. Other aetiologies were represented by bacterial pneumonias with or without abscesses 7.2%, pulmonary aspergilloma 6.9%, chronic bronchitis with or without emphysema 3.5% and by rare causes in 4 cases. The cause for the haemoptysis was not found in 3.1%. This study brings out the preponderant place of bronchial cancer as a cause of haemoptysis in a country which still has a high prevalence of tuberculosis. Nevertheless the existence of tuberculosis services where the greater part of tuberculosis patients are hospitalised explains in part the predominance of bronchial cancer increasing very rapidly in our service.

Adolescent↗
PubMed1988

[Smoking in Morocco: an outline of the anti-smoking campaign].

In Morocco, as in many developing countries, tobacco use has become a plague which aggravates the many already existing problems. A coordinated prevention programme which included research and a variety of educational efforts, has been underway for the past five years. The preliminary stage of the non-smoking campaign consisted of research through use of a variety of standardized questionnaires. The research results showed tobacco use in Morocco to be the following: 23.8% of secondary students are smokers with variation according to family, culture, environment and sex (33% male vs. 8.6% female); 33.8% of university students smoke, including those in Medical Schools; 52.1% of adults in the work environment smoke, including doctors. The rate declines drastically among practicing muslims (between the ages of 14 and 65) to 9.8%. The use of other drugs is significantly higher in students who use tobacco (25%) than those who do not (1.5%). A common factor appeared regardless of age, sex, or occupation: there was insufficient information available concerning the harmful effects of smoking. An educational campaign was therefore launched. As the youth were considered to be the most vulnerable target group, a major part of the educational efforts was concentrated on them. A variety of activities was implemented including conference-debates using audiovisual supports; radio and T.V. broadcasts; contests run with the assistance of the CIPADED (International Committee for the Prevention of Alcohol/Drug Dependence). Information of the harmful effects of tobacco use was diffused in workplaces, government offices, and at public assemblies. Efforts were also implemented to promote adoption of legislation which would limit tobacco consumption.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗
PubMed1982

[Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].

A preliminary study to determine the acetylator phenotype for Isoniazid was carried out for the first time on 100 patients. A correlation was shown between the blood and urinary methods; 59% were rapid acetylators and 41% slow acetylators, which were similar levels to those found in Black Africa. The predominance of rapid acetylators certainly explains the excellent tolerance of the high dose of INH (10 mg/kg) used in Morocco. If the determination of the acetylator phenotype could not be used systematically in our country, in view of the individual adaptation to the dosage--the dosage might, on the other hand be worked out in a prompt way before toxic signs appear at a dose of 10 mg/kg or under, of INH--thanks to the calculation of the index of inactivation estimated from a single sample.

Acetylation↗